tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Crispr, Sirius announce first patient dosed in SRSD107 Phase 2 trial
PremiumThe FlyCrispr, Sirius announce first patient dosed in SRSD107 Phase 2 trial
20d ago
Crispr Therapeutics AG Surges Amid Analyst Praise
Premium
Weekend Updates
Crispr Therapeutics AG Surges Amid Analyst Praise
22d ago
Deckers, Credo, Crispr, AeroVironment, Abercrombie: Trending by Analysts
Premium
Weekend Updates
Deckers, Credo, Crispr, AeroVironment, Abercrombie: Trending by Analysts
23d ago
Cathie Wood’s ARK Investment buys 340K shares of Crispr Therapeutics today
PremiumThe FlyCathie Wood’s ARK Investment buys 340K shares of Crispr Therapeutics today
25d ago
Cathie Wood Bets on AMD, Bullish, and Figma; Trims Tempus AI, Roku
Premium
Market News
Cathie Wood Bets on AMD, Bullish, and Figma; Trims Tempus AI, Roku
25d ago
CRSP, NTLA: Cathie Wood Adds to Biotech Favorites amid Buying Spree, Cuts Roku Stake
Premium
Market News
CRSP, NTLA: Cathie Wood Adds to Biotech Favorites amid Buying Spree, Cuts Roku Stake
1M ago
Cathie Wood Adds Over $11M in Biotech Stocks, Reduces Stakes in Roku and DraftKings
PremiumMarket NewsCathie Wood Adds Over $11M in Biotech Stocks, Reduces Stakes in Roku and DraftKings
2M ago
Cathie Wood Continues to Sell Roku, Invests $13M in CRISPR and Intellia
Premium
Market News
Cathie Wood Continues to Sell Roku, Invests $13M in CRISPR and Intellia
2M ago
Cathie Wood’s ARK Investment buys 189K shares of Crispr Therapeutics today
Premium
The Fly
Cathie Wood’s ARK Investment buys 189K shares of Crispr Therapeutics today
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100